Early statin therapy in SLE patients that have high cholesterol level and other atherosclerosis risk should reduce atherosclerosis and coronary artery events in later course of disease. By the way, statin is used in restricted groups of rheumatologists due to awareness of side effects; myositis and hepatitis, that are frequently found in SLE patients more so than other groups of atherosclerosis patients and reporting data of autoimmune diseases that occur after statin use.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
140
10 mg per day for 12 weeks
20 mg per day
Faculty of Medicine, Ramathibodi Hospital, Mahidol University
Bangkok, Thailand
RECRUITINGPercentage reduction of LDL Cholesterol level
Time frame: 6 and 12 weeks
Proportion of patients that have transminitis, myositis or active SLE
Time frame: 6,12, 18 and 24 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.